Provided By PR Newswire
Last update: Oct 21, 2025
SAN DIEGO, Oct. 21, 2025 /PRNewswire/ -- Halozyme Therapeutics, Inc. (NASDAQ: HALO) ("Halozyme") today announced it will release its third quarter 2025 financial and operating results on Monday, November 3, 2025, following the close of trading.
Read more at prnewswire.com65.77
-1.11 (-1.66%)
Find more stocks in the Stock Screener